marbocyl p 80 mg 80 mg tabl.
vétoquinol sa-nv - marbofloxacin 80 mg - tablet - 80 mg - marbofloxacin 80 mg - marbofloxacin - dog
marfloquin 80 mg tabl.
krka d.d. novo mesto d.d. - marbofloxacin 80 mg - tablet - 80 mg - marbofloxacin 80 mg - marbofloxacin - dog
odimar 80 mg tabl.
emdoka s.p.r.l.-b.v.b.a. - marbofloxacin 80 mg - tablet - 80 mg - marbofloxacin 80 mg - marbofloxacin - dog
quiflor 80 mg tabl.
krka d.d. novo mesto d.d. - marbofloxacin 80 mg - tablet - 80 mg - marbofloxacin 80 mg - marbofloxacin - dog
marbocyl p 80 mg tablets
vetoquinol ireland limited - marbofloxacin - tablet - 80 mg/tablet - marbofloxacin
marbofloxacin- marbofloxacin chewable tablets tablet, chewable
butler animal health supply, llc dba covetrus north america - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.
marfloxin 80 mg tablets for dogs
krka, d.d., novo mesto - marbofloxacin - tablet - 80 mg/tablet - marbofloxacin - dogs - antibacterial
marbocare flavour 80 mg tablets for dogs
emdoka - marbofloxacin - tablet - 80 mg/tablet - marbofloxacin - canine - antibacterial
boflox flavour 80 mg tablets for dogs
livisto int'l, s.l. - marbofloxacin - tablet - 80 mg/tablet - marbofloxacin - dogs - antibacterial
marbofloxacin tablet
zyvet animal health inc - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.